ALLEGRO MICROSYSTEMS, INC. financials

ALGM CIK 0000866291

Source: EDGAR filings · Built 2026-06-02T02:17:31Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Free Cash Flow 123.53M 20.76M 56.80M 113.43M 86.19M 79.90M
EBITDA 86.08M 44.70M 267.63M 254.12M 185.18M 60.47M
Working Capital 357.68M 370.77M 454.31M 500.50M 407.47M 313.89M
Net Debt 143.55M 254.35M 71.50M -309.04M -240.93M -172.21M
Gross Margin 46.28% 44.35% 54.75% 56.09% 53.01% 47.17%
Operating Margin 2.08% -2.73% 18.70% 20.88% 17.78% 2.06%
Net Margin -1.67% -10.07% 14.55% 19.24% 15.53% 3.04%
Return on Equity (ROE) -1.56% -7.85% 13.51% 19.40% 16.26% 3.06%
Return on Assets (ROA) -1.05% -5.14% 9.98% 15.86% 13.38% 2.40%
Current Ratio 3.45× 4.30× 4.85× 4.03× 4.91× 3.69×
Debt-to-Equity 0.33× 0.40× 0.25× 0.04× 0.06× 0.04×
Effective Tax Rate 1.66% 15.09% 21.51% 11.29% 15.06% 1347.48%
Cash Conversion Ratio -10.95× -0.85× 1.19× 1.03× 1.31× 6.72×
Accruals Ratio -0.13× -0.10× -0.02× -0.01× -0.04× -0.14×
SBC % of Revenue 5.38% 5.77% 4.05% 6.35% 4.36% 8.44%
CapEx Coverage 4.12× 1.50× 1.45× 2.42× 2.23× 2.96×
Free Cash Flow Per Share $0.67 $0.11 $0.29 $0.59 $0.45 $0.45

Valuation Metrics

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
P/E Trailing (Diluted) 34.56× 49.47× 47.06× 252.70×
P/FCF 45.12× 224.77× 92.39× 81.95× 64.95× 55.80×
FCF Yield 2.22% 0.44% 1.08% 1.22% 1.54% 1.79%
EV / EBITDA 66.53× 108.18× 19.73× 35.00× 28.71× 76.39×
P/S 6.27× 6.32× 4.96× 9.45× 7.23× 8.10×
P/B 5.85× 4.93× 4.61× 9.53× 7.57× 8.18×

Income Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Revenue from Contract with Customer, Excluding Assessed Tax 890.10M 725.01M 1.05B 973.65M 768.67M 591.21M
Cost of Goods and Services Sold 478.13M 403.48M 471.89M 348.39M 286.86M 254.28M
Gross Profit 411.97M 321.53M 574.53M 546.08M 407.46M 278.90M
Research and Development Expense 205.80M 179.65M 176.64M 150.85M 121.87M 108.65M
Selling, General and Administrative Expense 181.09M 161.68M 188.43M 191.92M 148.94M 153.48M
Operating Expenses 393.48M 341.33M 378.29M 342.77M 270.81M 266.74M
Operating Income (Loss) 18.49M -19.80M 196.24M 203.31M 136.65M 12.16M
Income Tax Expense (Benefit) -248.00K -12.93M 41.91M 23.85M 21.19M -19.55M
Net Income (Loss) Attributable to Parent -14.90M -73.01M 152.70M 187.36M 119.41M 17.95M
Earnings Per Share, Basic $-0.08 $-0.39 $0.79 $0.98 $0.63 $0.22
Weighted Average Number of Shares Outstanding, Basic 185.04M 187.71M 192.57M 191.20M 189.75M 83.45M
Earnings Per Share, Diluted $-0.08 $-0.39 $0.78 $0.97 $0.62 $0.10
Weighted Average Number of Shares Outstanding, Diluted 185.04M 187.71M 194.67M 193.69M 191.81M 176.42M

Balance Sheet

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Cash and Cash Equivalents, at Carrying Value 168.75M 121.33M 212.14M 351.58M 282.38M 197.21M
Assets, Current 503.61M 483.04M 572.21M 665.83M 511.69M 430.56M
Assets 1.42B 1.42B 1.53B 1.18B 892.62M 747.68M
Long-term Debt 280.88M 338.93M 245.10M 25.00M 25.00M 25.00M
Liabilities, Current 145.93M 112.26M 117.91M 165.32M 104.22M 116.67M
Long-term Debt, Excluding Current Maturities 285.75M 344.70M 249.61M 25.00M 25.00M 25.00M
Liabilities 459.73M 489.86M 398.89M 214.34M 157.26M 160.81M
Stockholders' Equity Attributable to Parent 954.75M 929.55M 1.13B 965.63M 734.21M 585.75M
Common Stock, Shares, Outstanding 185.36M 184.29M 193.16M 191.75M 190.47M 189.59M

Cash Flow Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Net Cash Provided by (Used in) Operating Activities 163.07M 61.91M 181.72M 193.21M 156.13M 120.57M
Payments to Acquire Property, Plant, and Equipment 38.18M 39.95M 124.77M 79.78M 69.94M 40.67M
Net Cash Provided by (Used in) Investing Activities -41.72M -40.82M -516.72M -99.70M -66.27M -68.25M
Payments for Repurchase of Common Stock 0 853.92M 0 0
Payments of Dividends 0 400.00M
Net Cash Provided by (Used in) Financing Activities -77.38M -112.06M 198.88M -20.00M -5.31M -72.19M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (ALGM CIK 0000866291), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

XCUR

EXICURE, INC.

ETON

Eton Pharmaceuticals, Inc.

OBT

Orange County Bancorp, Inc.